SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $457,612 | +17.4% | 2,157 | +6.5% | 0.01% | +20.0% |
| Q2 2023 | $389,928 | -6.8% | 2,026 | -2.0% | 0.01% | -9.1% |
| Q1 2023 | $418,506 | +166.5% | 2,067 | +69.1% | 0.01% | +120.0% |
| Q4 2022 | $157,039 | -20.7% | 1,222 | -15.7% | 0.01% | -28.6% |
| Q3 2022 | $198,000 | -25.6% | 1,450 | -3.6% | 0.01% | -22.2% |
| Q2 2022 | $266,000 | +57.4% | 1,504 | +28.2% | 0.01% | +80.0% |
| Q1 2022 | $169,000 | +96.5% | 1,173 | +111.0% | 0.01% | +66.7% |
| Q4 2021 | $86,000 | -29.5% | 556 | -22.5% | 0.00% | -25.0% |
| Q3 2021 | $122,000 | +60.5% | 717 | +48.1% | 0.00% | +33.3% |
| Q2 2021 | $76,000 | +35.7% | 484 | +19.8% | 0.00% | +50.0% |
| Q1 2021 | $56,000 | -8.2% | 404 | +16.4% | 0.00% | -33.3% |
| Q4 2020 | $61,000 | – | 347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |